Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The FDA classified BPC-157 as a Category 2 bulk drug substance in 2023, meaning it cannot be compounded by commercial pharmaceutical companies and there is insufficient evidence regarding potential human harm
Most peptides degrade within minutes in biological systems, yet BPC-157 persists long enough to trigger sustained cellular responses
Published Research on the Component Compounds GHK-Cu Genome-Wide Gene Expression Pickart et al., BioMed Research International (2015) This widely-cited review and analysis paper synthesizes the mechanistic case for GHK-Cus effects on dermal and tissue repair
IN-VITRO RESEARCH ONLY NOT FOR HUMAN USE DSIP Product information $49.99 Product description DSIP research compound, also known as Delta Sleep-Inducing Peptide
Why Source and Medical Supervision Matter This is where most BPC-157 conversations go off the rails
US$ 28.87
US$ 27.86
US$ 22.46
US$ 20.71
US$ 23.54
US$ 27.64
